Please assess the completion status of the following clinical trial:

Trial Title: Reduced Intensity AlloTransplant For Osteopetrosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients eligible for transplantation under this protocol will be \<45 years of age, and will be diagnosed with severe osteopetrosis. This will be defined as having the following manifestations of the disease.~* Bones that are uniformly markedly dense based on skeletal survey~* No history that would suggest autosomal dominant inheritance~* Evidence of hematologic changes that are attributed to the underlying disease, including the need for ongoing transfusions, OR~* the presence of progressive anemia or thrombocytopenia, OR a white blood cell differential with a predominance of immature forms and evidence of extramedullary hematopoiesis, OR~* persistence of serious infectious complications that are thought to be due to the abnormal architecture of the bone that are resistant to surgical and medical interventions.~Exclusion Criteria:~* Patients \>45 years of age~* Evidence of hepatic failure~* pulmonary dysfunction sufficient to substantially increase the risk of transplant~* Renal dysfunction with glomerular filtration rate (GFR) \<30% of predicted.~* Cardiac compromise sufficient to substantially increase the risk of transplantation~* Severe, stable neurologic impairment.~* Human immunodeficiency virus (HIV) positivity.~* Pregnant or lactating females

- Gender: ALL
- Minimum Age: None
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Intent-To-Treat (Type: EXPERIMENTAL): Patients enrolled and received study treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).